Title:
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, COMPRISING MUTANT RON INHIBITOR AND ANTI-PD-1 ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2023/195807
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for cancer prevention or treatment, comprising a mutant RON inhibitor or a pharmaceutically acceptable salt thereof, and to a pharmaceutical composition and a use thereof, the pharmaceutical composition being administered by having a mutant RON inhibitor or a pharmaceutically acceptable salt thereof combined with an anti-PD-1 antibody.
Inventors:
SON HYE-JIN (KR)
LEE MI-SO (KR)
KIM HYO-JIN (KR)
KIM HA-NA (KR)
LEE JUN-HYUNG (KR)
SHIN WON-HWA (KR)
LEE MI-SO (KR)
KIM HYO-JIN (KR)
KIM HA-NA (KR)
LEE JUN-HYUNG (KR)
SHIN WON-HWA (KR)
Application Number:
PCT/KR2023/004682
Publication Date:
October 12, 2023
Filing Date:
April 06, 2023
Export Citation:
Assignee:
WELLMARKER BIO CO LTD (KR)
International Classes:
C07D495/04; A61K31/5377; A61K45/06; A61P35/00
Foreign References:
| KR20210142555A | 2021-11-25 | |||
| KR20220013511A | 2022-02-04 | |||
| KR20210142554A | 2021-11-25 | |||
| KR20210142553A | 2021-11-25 | |||
| KR20190043162A | 2019-04-25 |
Attorney, Agent or Firm:
FIRSTLAW P.C. (KR)
Download PDF:
Previous Patent: ELECTRONIC DEVICE AND OPERATION METHOD THEREFOR
Next Patent: METHOD FOR DETERMINING TIMING FOR REQUESTING MUSIM GAPS
Next Patent: METHOD FOR DETERMINING TIMING FOR REQUESTING MUSIM GAPS